000 06566nam a22004815i 4500
999 _c200458139
_d76351
003 DE-He213
005 20231109085856.0
007 cr nn 008mamaa
008 220413s2022 sz | s |||| 0|eng d
020 _a9783030925895
024 7 _a10.1007/978-3-030-92589-5
_2doi
040 _aTR-AnTOB
_beng
_erda
_cTR-AnTOB
060 _aWP 320
072 7 _aMFKC
_2bicssc
072 7 _aHEA039060
_2bisacsh
072 7 _aMFKC
_2thema
096 _aWP320EBK
245 1 0 _aPolycystic Ovary Syndrome
_h[electronic resource] :
_bCurrent and Emerging Concepts /
_cedited by Lubna Pal, David B. Seifer.
250 _a2nd ed. 2022.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2022.
300 _a1 online resource
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPart I. Epidemiology of Polycystic Ovary Syndrome -- 1. Diagnostic Criteria and Epidemiology of PCOS -- 2. Prevalence, Presentation, and Diagnosis of PCOS in Adolescents -- 3. Polycystic Ovarian Syndrome: A Diagnosis of Exclusion -- Part II. Pathophysiology, Endocrine and Metabolic Milieus of Polycystic Ovary Syndrome -- 4. Recent Advances in the Genetics of Polycystic Ovary Syndrome -- 5. The Hypothalamo-Pituitary Axis in PCOS -- 6. Ovarian Dysfunction in Polycystic Ovary Syndrome (PCOS) -- 7. The Role of the Adrenal Glands in the Hyperandrogenism associated with the Polycystic Ovarian Syndrome -- 8. Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences -- 9. Obesity, Dysmetabolic and Proinflammatory Milieu of Polycystic Ovary Syndrome -- Part III. Management of Polycystic Ovary Syndrome -- 10. Managing PCOS in the Adolescent -- 11. Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Female Pattern Hair Loss -- 12. Role of Insulin-Sensitizing Drugs in PCOS Management -- 13. Role of Statins & Resveratrol in PCOS Management -- 14. Role of Lifestyle, Diet and Exercise in the Management of Polycystic Ovarian Syndrome -- Part IV. Management of Polycytic Ovary Syndrome Related Infertility -- 15. Managing PCOS-Related Infertility: Ovulation Induction, In Vitro Fertilization, and In Vitro Maturation -- 16. Considerations and Challenges for Pregnancy in Polycystic Ovary Syndrome -- Part V. The Role of Surgery in the Management of Polycystic Ovary Syndrome -- 17. Rationale and considerations for Bariatric Surgery -- 18. Surgical Management of Polycystic Ovary Syndrome: A Contemporary Viewpoint on Place of Ovarian Surgery in PCOS Management -- Part VI. Health Risks and Burden of Polycystic Ovary Syndrome -- 19. PCOS and its Association with Mental Health -- 20. Obstructive Sleep Apnea in Polycystic Ovary Syndrome -- 21. Endometrial cancer and pre-cancer in polycystic ovary syndrome -- 22. Economic Burden of Polycystic Ovary Syndrome -- Part VII. Emerging Concepts in Polycystic Ovary Syndrome -- 23. The Role of Angiogenic Factor Dysregulation in the Pathogenesis of Polycystic Ovarian Syndrome -- 24. Emerging Concepts: Role of Vitamin D Deficiency in the Pathogenesis of PCOS -- 25. Anti-Mullerian Hormone Signaling – relevance for pathophysiology of PCOS & implications for novel therapeutic approaches to managing ovulatory dysfunction of PCOS -- 26. Newer Glucose Lowering Medications and Potential Role in Metabolic Management of PCOS -- 27. Intergenerational Implications of PCOS.
520 _aNow in a completely newly revised and expanded second edition, this comprehensive text presents the current state of the art in our understanding and management of polycystic ovary syndrome (PCOS), the most common hormonal disorder of reproductive aged women. The numerous bothersome symptoms of PCOS include menstrual irregularities, hirsutism, acne, scalp hair thinning, weigh excess and infertility; additionally, as they age, women with PCOS are at a higher risk for metabolic abnormalities such as diabetes and dyslipidemias, as well as for cardiovascular disease and even certain cancers. Despite improvements in our understanding of this condition, the exact cause/s of PCOS remain elusive; genetic, hormonal, metabolic and environmental underpinnings are all suggested as relevant. All chapters have been updated, with eight new chapters added across seven thematic sections. Part one discusses the epidemiology of PCOS in both adults and adolescents. Part two covers the pathophysiology of PCOS, including genetics, the hypothalamo-pituitary-ovarian and the hypothalamo-pituitary-adrenal axes, insulin resistance, inflammation, and obesity. The next three sections present the various management strategies, medical and surgical, for harnessing the symptomatology, including PCOS-related infertility; these chapters include added case material to provide real-world examples of the treatments in action and their efficacy. Part six covers the comorbidities that women with PCOS commonly encounter, such as issues of mental health, sleep disturbances, endometrial hyperplasia, and cancer, as well as examines the economic burden of PCOS. The final section discusses emerging concepts surrounding possible mechanisms and potential therapeutic approaches to PCOS, including angiogenic dysfunction, the role of vitamin D, future potential therapies to targeted AMH signaling. The closing chapter, by familiarizing the readers with the intergenerational implications of PCOS and by raising awareness of potential “ripple effects”, aims at alerting the community on a need for vigilance as regards the health of PCOS progeny. With contributions from leaders in the field, Polycystic Ovary Syndrome, Second Edition remains the gold-standard text on this common medical condition and a valuable resource for the wide range of healthcare professionals engaged in caring for the women with PCOS.
650 0 _aReproductive health.
650 0 _aGynecology .
650 1 4 _aReproductive Medicine.
650 2 4 _aGynecology.
653 0 _aPolycystic Ovary Syndrome
700 1 _aPal, Lubna.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aSeifer, David B.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
856 4 0 _uhttps://doi.org/10.1007/978-3-030-92589-5
_3Springer eBooks
_zOnline access link to the resource
942 _2NLM
_cEBK
041 _aeng